Tissue Regenix Group (LON:TRX) Share Price Passes Below 200-Day Moving Average – What’s Next?

Tissue Regenix Group plc (LON:TRX – Get Free Report) shares crossed below its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of GBX 60.24 ($0.73) and traded as low as GBX 57 ($0.69). Tissue Regenix Group shares last traded at GBX 57.03 ($0.69), with a volume of 4,648 shares traded.

Tissue Regenix Group Price Performance

The firm has a market capitalization of £40.67 million, a P/E ratio of -5,709.00 and a beta of 1.61. The company has a current ratio of 3.74, a quick ratio of 2.36 and a debt-to-equity ratio of 35.69. The firm has a 50 day moving average price of GBX 58.26 and a 200-day moving average price of GBX 60.16.

Tissue Regenix Group Company Profile

(Get Free Report)

Tissue Regenix is a leading medical device company in regenerative medicine. The Company’s patented decellularisation technology (dCELL®) removes DNA and other cellular material from animal and human soft tissue, leaving an acellular tissue scaffold not rejected by the patient’s body that can be used to repair diseased or damaged body structures.

Featured Stories

• Five stocks we like better than Tissue Regenix Group
• 3 REITs to Buy and Hold for the Long Term
• AI Demand Sparks Opportunities for These 3 Nuclear Energy Leaders
• What Do S&P 500 Stocks Tell Investors About the Market?
• TSMC: Long-Term Outlook Still Strong as Geopolitical Risk Rises
• What is the Shanghai Stock Exchange Composite Index?
• Uber’s NVIDIA Deal and Buybacks Signal Major Upside